Etiqueta: EV

Support CleanTechnica's work through a Substack subscription or on Stripe. This is my second article on the recent visit of a large but select group of journalists to BYD’s Shenzhen factory and headquarters, and to the Zhengzhou tech center in China. I saw and experienced BYD’s groundbreaking electric vehicle innovations ... [continued]

BEIJING (Reuters) -Chinese electric car makers invested more abroad than at home for the first time in 2024, new data from Rhodium Group showed on Wednesday, as fierce domestic competition makes it almost impossible for manufacturers to turn a profit. Automakers have benefited from years of subsidies and other government policies aimed at making China a global automotive power and the world's leader in electric vehicles, but overcapacity and aggressive price cutting have sent the industry into a tailspin. Automakers in the world's No. 2 economy are locked in relentless price wars that are deepening deflationary pressures, while fears of a flood of cheap Chinese cars have sparked trade tensions with key partners — strain the export-driven economy can ill-afford amid U.S. President Donald Trump's tariffs.

Zacks highlights Tesla, Alphabet, Nio, XPeng, and BYD, with Tesla poised for a Q3 delivery beat fueled by Model Y updates, China demand, and renewed focus from Elon Musk.

Hungary is backing BYD’s growth with an HUF 3.1bn grant, positioning itself as a Chinese EV hub. By Stewart Burnett

BYD is bringing China’s EV price war, which it helped ignite, overseas. After launching steep discounts of up to 50%...

BYD (BYDDY) stock fell 5% in September as Japan EV sales disappoint and Berkshire Hathaway exits its 15-year stake, raising investor concerns.

The official local agent of the Chinese electric vehicle manufacturer BYD in Sri Lanka on Sunday advertised a plug-in hybrid version instead of a full EV that

Stocks to watch this morning include CoreWeave (CRWV), the NVIDIA (NVDA)-backed AI cloud scaler, which is rising after some big swings in recent weeks. In the pharmaceutical sector, AstraZeneca (AZN) gains as it announces plans to list in New York, while GSK (GSK) and UCB SA (UCB.BR) are up on appointing a new CEO and positive trial results, respectively. And it's a high-stakes moment for Tesla (TSLA), BYD (1211.HK) and other makers of electric vehicles, amid a global slowdown and as a $7,500 tax credit comes to an end in the US. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.